Abstract Library
Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.
Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.
ENETS Abstract Search
Introduction: 18F-DOPA PET/CT is a powerful diagnostic test for assessing tumour burden in midgut neuroendocrine tumours (NETs). 68Ga-DOTATOC PET/CT is required for patient selection for PRRT.
Conference:
Presenting Author: Longo M
Authors: Longo M, Coccarelli A, Henry T, Kamoun T, Morbelli S,
Keywords: F-DOPA, Ga-DOTATOC, PRRT, midgut,
Introduction: Paragangliomas (PGLs) are rare neuroendocrine tumours with variable clinical outcomes. Early identification of prognostic markers is essential for effective disease management. PET/CT imaging with 68Ga-DOTANOC, 18F-DOPA, and 18F-FDG offers unique insights into tumour biology, respectively.
Conference:
Presenting Author: Xu J
Authors: Gao J, Xu J, Liang Y, Chen J, Song S,
Keywords: PET/CT, paraganglioma, prognosis,
Introduction: Refractory carcinoid syndrome (RCSy) could lead to severe complications.
Conference:
Presenting Author: Tőke J
Authors: Tőke J, Kövesdi A, Szolnoky J, Huszty G, Piros L,
Keywords: refractory carcinoid syndrome, liver transplantation, ileum neuroendocrine tumor,
Introduction: Functional imaging is important for precise treatment for metastatic paraganglioma (PGL).
Conference:
Presenting Author: Xu J
Authors: Bian L, Xu J, Xu X, Chen J, Song S,
Keywords: paraganglioma, 18F-FDG, 68Ga-DOTANOC, 18F-DOPA, PET/CT,
Introduction: In treatment of neuroendocrine neoplasms (NENs), confirmation of somatostatin receptor affinity with 68Ga-DOTA, is mandatory to determine eligibility for peptide receptor radionuclide therapy (PRRT). 18F-FDOPA tracer is also used in the diagnostic imaging of NENs, likely detecting additional lesions compared to 68Ga-DOTA.
Conference: 18th Annual ENETS Concerence (2021)
Presenting Author:
Authors: Veenstra E, Noordzij W,
Keywords: neuroendocrine tumor, PET tracer, 18F-DOPA, 68Ga-DOTA-TOC, carbidopa, peptide receptor radionuclide therapy, PRRT,